The provision in the Affordable Care Act to remove cost sharing for preventive care visits created a shift in how Medicare pays with a greater emphasis on prevention and managing chronic diseases, and less on treatment of acute illness, said Mariétou Ouayogodé, PhD, post-doctoral fellow at The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth.
The provision in the Affordable Care Act to remove cost sharing for preventive care visits created a shift in how Medicare pays with a greater emphasis on prevention and managing chronic diseases, and less on treatment of acute illness, said Mariétou Ouayogodé, PhD, post-doctoral fellow at The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth.
Transcript
How is Medicare becoming more focused on prevention instead of just treatment?
First, you have something that led up to Medicare doing that and that is the provision in the Affordable Care Act removing cost sharing for preventive care visits. And the way Medicare is approaching shifting attention to prevention rather than treatment with accountable care organizations (ACOs) is to focus management or treatment of the entire population. So not just focusing on individuals with acute illnesses, as it was done before.
So before the traditional way of practicing was to manage or even treat individuals with acute illnesses. So usually this will take a lot of time in patients' visits and it will leave very little time to talk about prevention or even chronic care management needs. But now with ACOs, providers have to see patients on the whole spectrum of health statuses and they also have to meet some benchmark on quality measures, meaning they're going to be paid for keeping their patients healthy and out of the hospital.
So now there is more emphasis on prevention and chronic care management than before. So this is how Medicare is actually changing or shifting attention to prevention rather than treatment. But this is not to say that treatment is not effective, but prevention does help essentially reduce costs basically in the long run.
Health Care Utilization and Cost of Diagnostic Testing for Respiratory Infections
September 17th 2025Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved value in patient care.
Read More
ACA Network Regulatory Filings Are Inaccurate, Poorly Match Provider Directories
September 16th 2025A secret shopper survey (N = 8306) in Pennsylvania’s Affordable Care Act (ACA) Marketplace found inconsistencies between carrier regulatory filings and provider directories, frequent inaccuracies in regulatory filings, and challenges in securing timely appointments.
Read More
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More